BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
W6QK ACC-APG
Contract Value
Not provided
Codes & Classification
Solicitation Number
CBRND-BAA-22-01
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Classification Code
AC12
Additional Details
Documents1
The Department of Defense, through the Department of the Army and its contracting entity W6QK ACC-APG, has issued a Broad Agency Announcement (BAA) under procurement identifier CBRND-BAA-22-01. This solicitation seeks to advance research and development in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), specifically targeting the Joint Project Management Office for Medical (JPM Medical) and the Joint Project Lead for Enhanced Biodefense (JPL EB).
The primary purpose of this BAA is to identify and leverage the best available science within the defined mission areas, as detailed in Section VII of the announcement. The scope encompasses a wide range of research interests, with particular emphasis on innovative solutions and improved methodologies for the rapid and efficient development of medical countermeasures. Key areas of focus include enabling technologies, life cycle bioinformatics, and enhanced logistics tracking, all aimed at strengthening the nation’s defense against chemical, biological, radiological, and nuclear threats.
Eligible offerors include educational institutions, nonprofit organizations, and private industry, reflecting the government’s commitment to fostering broad participation and harnessing diverse expertise. Proposals may be submitted at any time while the announcement remains active, and unsolicited preproposals are welcomed under the general requirements of the BAA. The government may also issue special announcements or calls for proposals referencing this BAA to address specific requirements as they arise.
The expected deliverables are research studies, technical solutions, and methodologies that directly support the mission areas of JPEO-CBRND. Offerors are encouraged to engage with JPMO technical contacts listed in Section VII (B) to discuss proposal concepts and ensure alignment with government objectives. Administrative inquiries regarding proposal preparation should be directed to the U.S. Army Contracting Command Edgewood Contracting Division/Grants Officer via the designated email address: [email protected], with attention to CBRND BAA 22-01.
The place of performance for awarded projects is Frederick, Maryland, USA. The procurement is classified under NAICS code 541715, which pertains to Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), and product service code AC12. The contracting entity operates as a federal office within the Department of Defense, Department of the Army.
This BAA is an open solicitation, with no specified set-aside requirements, inviting participation from all eligible entities. The announcement and any amendments will be accessible via Grants.gov, SAM.gov, and the JPEO-CBD website. The opportunity remains active, with a response deadline set for January 1, 2031.
For further information or to discuss technical and administrative matters, potential offerors may contact Joseph McCaffery ([email protected]) or Keith Pereira ([email protected]). The official solicitation and additional details can be found at https://sam.gov/opp/e7c3faad3433434aaf41a5eb5ce11920/view.
Contractors considering this opportunity should evaluate their capabilities in advanced research and development, particularly in medical countermeasures and supporting technologies, and ensure their proposals address the government’s objectives for rapid innovation and operational efficiency in CBRN defense.